[1]
A. . Solis Chiriboga and A. Bustillos, “Review of the Use of Antisense Oligonucleotides as Therapy for Huntington’s Disease”, Salud, Ciencia y Tecnología - Serie de Conferencias, vol. 3, p. 923, Jan. 2024, doi: 10.56294/sctconf2024923.